Vinva Investment Management Ltd

Position in JAZZ — Jazz Pharmaceuticals plc

CIK 1968109 SYDNEY, C3

Position in JAZZ

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$2,106,395

+$1,409,565 QoQ

Shares Held

11,142

+171.8% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Vinva Investment Management Ltd holds $66,411,479 across 13 Biotechnology names. JAZZ ranks #6 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	300,405	$28,274,118
2	ALNY	Alnylam Pharmaceuticals, Inc.	36,601	$12,110,172
3	REGN	Regeneron Pharmaceuticals, Inc.	14,862	$11,482,975
4	VRTX	Vertex Pharmaceuticals Inc / Ma	9,531	$4,255,972
5	EXEL	Exelixis, Inc.	49,204	$2,110,359
6	JAZZ	Jazz Pharmaceuticals plc This page	11,142	$2,106,395
7	HALO	Halozyme Therapeutics, Inc.	32,126	$2,076,303
8	ASND	Ascendis Pharma A/S	5,694	$1,302,388

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,106,395	11,142	+171.8%	Shares	Sole	2026-05-14
2025-12-31	$696,830	4,099	+40.0%	Shares	Sole	2026-02-17
2025-06-30	$310,719	2,928	+100.8%	Shares	Sole	2025-08-13
2025-03-31	$181,010	1,458	-49.7%	Shares	Sole	2025-05-14
2024-12-31	$356,765	2,897	+82.7%	Shares	Sole	2025-02-11
2024-09-30	$176,696	1,586	-6.9%	Shares	Sole	2024-11-14
2024-03-31	$205,195	1,704	0.0%	Shares	Sole	2024-05-13
2023-12-31	$209,592	1,704	-28.6%	Shares	Sole	2024-02-13
2023-09-30	$308,714	2,385	+22.6%	Shares	Sole	2023-11-13
2023-06-30	$241,121	1,945	-21.9%	Shares	Sole	2023-08-14
2023-03-31	$364,508	2,491	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.